PLATELET-ACTIVATING-FACTOR AND CEREBRAL VASOSPASM FOLLOWING SUBARACHNOID HEMORRHAGE

被引:23
|
作者
HIRASHIMA, Y [1 ]
ENDO, S [1 ]
OTSUJI, T [1 ]
KARASAWA, K [1 ]
NOJIMA, S [1 ]
TAKAKU, A [1 ]
机构
[1] TEIKYO UNIV, FAC PHARMACEUT SCI, SAGAMIKO, KANAGAWA 19901, JAPAN
关键词
SUBARACHNOID HEMORRHAGE; VASOSPASM; PLATELET-ACTIVATING FACTOR; ANTIPLATELET-ACTIVATING FACTOR; IMMUNOGLOBULIN-G;
D O I
10.3171/jns.1993.78.4.0592
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study examines whether platelet-activating factor (PAF) is involved in the occurrence of vasospasm after subarachnoid hemorrhage (SAH). A vasospasm model was produced in rabbits, with animals in six experimental groups receiving two subarachnoid injections of autologous arterial blood with the addition of one of the following: saline (Control Group 1), 25% dimethyl sulfoxide (Control Group 2), PAF (1, 2.5, 5, or 10 mug), CV6209 (10 or 100 mug), BN52021 (10 or 100 mug), or anti-PAF immunoglobulin G (IgG, 50 or 500 mug). No significant differences were detected between Control Groups 1 and 2 with regard to neurological deterioration and basilar artery constriction after SAH was induced. Administration of PAF together with autologous blood aggravated neurological deficits in a dose-dependent manner (r = 0.724, p < 0.001) and produced basilar artery constriction at two doses each of 2.5 mug (p < 0.05), 5 mug (p < 0.01), and 10 mug (p < 0.0 1). Neurological deterioration was prevented in rabbits receiving an intracisternal administration of either PAF antagonist CV6209 or BN52021 or anti-PAF IgG (p < 0.01 at a total dose of 20 mug and p < 0.05 at a total dose of 200 mug CV6209, p < 0.01 at total doses of 20 and 200 mug BN52021, and p < 0.01 at total doses of 100 and 1000 mug anti-PAF IgG). A reduction in basilar artery constriction was achieved by the injection of anti-PAF IgG (p < 0.05 at total doses of 100 and 1000 mug). Histological examination at autopsy on Days 14 to 21 showed mainly ischemic changes in the brain, including selective neuronal necrosis and cerebral infarction. The control and PAF groups showed marked ischemic changes. On the other hand, no ischemic changes were noted in the anti-PAF IgG group, and only 9% of animals in the CV6209 group and 25% in the BN52021 group demonstrated selective neuronal necrosis or infarction. This study thus provides evidence to support the role of PAF in the pathogenesis of vasospasm after SAH.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 50 条
  • [41] Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage
    Ostrowski, Robert P.
    Zhang, John H.
    TRANSLATIONAL STROKE RESEARCH, 2011, 2 (03) : 316 - 327
  • [42] The effect of thiocolchicoside on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit
    Hayri Kertmen
    Bora Gürer
    Erdal Resit Yilmaz
    Ata Türker Arikok
    Adnan Demirci
    Salih Metin Gökyaprak
    Zeki Sekerci
    Acta Neurochirurgica, 2012, 154 : 1431 - 1436
  • [43] DOES THROMBIN PREVENT CEREBRAL VASOSPASM FOLLOWING ANEURYSMAL SUBARACHNOID HEMORRHAGE
    ONEILL, P
    WALTON, S
    FOY, PM
    SHAW, MDM
    BRITISH JOURNAL OF NEUROSURGERY, 1992, 6 (04) : 313 - 320
  • [44] Cilostazol May Prevent Cerebral Vasospasm Following Subarachnoid Hemorrhage Commentary
    Weaver, Michael W.
    Loftus, Christopher M.
    Xu, Bin
    Zhou, Liang-Fu
    NEUROLOGIA MEDICO-CHIRURGICA, 2009, 49 (06) : 240 - 241
  • [45] Risk Factors Associated with Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage
    Inagawa, Tetsuji
    Yahara, Kaita
    Ohbayashi, Naohiko
    NEUROLOGIA MEDICO-CHIRURGICA, 2014, 54 (06) : 465 - 473
  • [46] A RANDOM FOREST CLASSIFIER FOR PREDICTING CEREBRAL VASOSPASM FOLLOWING SUBARACHNOID HEMORRHAGE
    Zarrin, David
    Wilson, Bayard
    Gaonkar, Bilwaj
    Macyszyn, Luke
    Gabel, Eilon
    ANESTHESIA AND ANALGESIA, 2022, 134 (4S_SUPPL): : 56 - 56
  • [47] Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage
    Asano, T
    Matsui, T
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1999, 19 (01) : 31 - 44
  • [48] New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage
    Crowley, R. Webster
    Medel, Ricky
    Kassell, Neal F.
    Dumont, Aaron S.
    DRUG DISCOVERY TODAY, 2008, 13 (5-6) : 254 - 260
  • [49] “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage
    Kendall H. Lee
    Timothy Lukovits
    Jonathan A. Friedman
    Neurocritical Care, 2006, 4 : 68 - 76
  • [50] Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage
    Robert P. Ostrowski
    John H. Zhang
    Translational Stroke Research, 2011, 2 : 316 - 327